|
Re: Its tax season and I am playing with numbers…
|
3
|
Resverlogix Corp.
|
Mar 30, 2024 08:35AM
|
|
Pfizer
|
5
|
Zenith Epigenetics
|
Mar 11, 2024 07:39AM
|
|
Lu stepping down
|
3
|
Resverlogix Corp.
|
Feb 21, 2024 07:08PM
|
|
Re: Long Covid
|
2
|
Resverlogix Corp.
|
Jan 21, 2024 09:16PM
|
|
Re: RVXs up or down draft from ZENE???
|
3
|
Resverlogix Corp.
|
Jan 09, 2024 08:19PM
|
|
Re: Questrade
|
|
Zenith Epigenetics
|
Jan 07, 2024 06:30PM
|
|
Re: Questrade
|
2
|
Zenith Epigenetics
|
Jan 05, 2024 11:25PM
|
|
Re: Questrade
|
1
|
Zenith Epigenetics
|
Jan 05, 2024 12:41PM
|
|
Questrade
|
|
Zenith Epigenetics
|
Jan 05, 2024 09:54AM
|
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jan 04, 2024 07:35AM
|
|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jan 03, 2024 09:36PM
|
|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jan 03, 2024 05:13PM
|
|
Re: Happy New Years
|
6
|
Resverlogix Corp.
|
Dec 30, 2023 05:35PM
|
|
The crick didn’t rise, here’s the presentation, finally!
|
5
|
Zenith Epigenetics
|
Oct 27, 2023 05:31PM
|
|
Re: Could it be
|
2
|
Zenith Epigenetics
|
Oct 27, 2023 11:05AM
|
|
Re: Notice anything different about #11
|
4
|
Zenith Epigenetics
|
Oct 26, 2023 10:10PM
|
|
Re: ACCORDING TO "GlobalData" https://www.globalda...
|
2
|
Resverlogix Corp.
|
Oct 26, 2023 09:08AM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
2
|
Resverlogix Corp.
|
Oct 04, 2023 01:49PM
|
|
Can we seek funding for this?
|
3
|
Resverlogix Corp.
|
Oct 04, 2023 07:59AM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
5
|
Resverlogix Corp.
|
Aug 29, 2023 06:49PM
|
